345 related articles for article (PubMed ID: 22465878)
1. Estrogen receptor-beta and breast cancer: translating biology into clinical practice.
Leung YK; Lee MT; Lam HM; Tarapore P; Ho SM
Steroids; 2012 Jun; 77(7):727-37. PubMed ID: 22465878
[TBL] [Abstract][Full Text] [Related]
2. The changes of estrogen receptor-beta variants expression in breast carcinogenesis: Decrease of estrogen receptor-beta2 expression is the key event in breast cancer development.
Park BW; Kim KS; Heo MK; Yang WI; Kim SI; Kim JH; Kim GE; Lee KS
J Surg Oncol; 2006 May; 93(6):504-10. PubMed ID: 16615154
[TBL] [Abstract][Full Text] [Related]
3. Suppression of ERβ signaling via ERβ knockout or antagonist protects against bladder cancer development.
Hsu I; Chuang KL; Slavin S; Da J; Lim WX; Pang ST; O'Brien JH; Yeh S
Carcinogenesis; 2014 Mar; 35(3):651-61. PubMed ID: 24148819
[TBL] [Abstract][Full Text] [Related]
4. Clinical significance of estrogen receptor beta in breast cancer.
Saji S; Hirose M; Toi M
Cancer Chemother Pharmacol; 2005 Nov; 56 Suppl 1():21-6. PubMed ID: 16273360
[TBL] [Abstract][Full Text] [Related]
5. Cancer-associated fibroblasts promote cisplatin resistance in bladder cancer cells by increasing IGF-1/ERβ/Bcl-2 signalling.
Long X; Xiong W; Zeng X; Qi L; Cai Y; Mo M; Jiang H; Zhu B; Chen Z; Li Y
Cell Death Dis; 2019 May; 10(5):375. PubMed ID: 31076571
[TBL] [Abstract][Full Text] [Related]
6. Estrogen receptor beta in breast cancer.
Haldosén LA; Zhao C; Dahlman-Wright K
Mol Cell Endocrinol; 2014 Jan; 382(1):665-672. PubMed ID: 23954741
[TBL] [Abstract][Full Text] [Related]
7. [Estrogen receptor Beta isoforms -- functions and clinical relevance in breast cancer].
Mitter D; Ortmann O; Treeck O
Zentralbl Gynakol; 2005 Aug; 127(4):228-34. PubMed ID: 16037904
[TBL] [Abstract][Full Text] [Related]
8. Estrogen Receptor β Expression and Its Clinical Implication in Breast Cancers: Favorable or Unfavorable?
Choi Y
J Breast Cancer; 2022 Apr; 25(2):75-93. PubMed ID: 35380018
[TBL] [Abstract][Full Text] [Related]
9. Estrogen receptor beta exerts growth-inhibitory effects on human mammary epithelial cells.
Treeck O; Lattrich C; Springwald A; Ortmann O
Breast Cancer Res Treat; 2010 Apr; 120(3):557-65. PubMed ID: 19434490
[TBL] [Abstract][Full Text] [Related]
10. Estrogen receptor beta impacts hormone-induced alternative mRNA splicing in breast cancer cells.
Dago DN; Scafoglio C; Rinaldi A; Memoli D; Giurato G; Nassa G; Ravo M; Rizzo F; Tarallo R; Weisz A
BMC Genomics; 2015 May; 16(1):367. PubMed ID: 25956916
[TBL] [Abstract][Full Text] [Related]
11. ERβ Isoforms Have Differential Clinical Significance in Breast Cancer Subtypes and Subgroups.
Choi Y; Kim H; Pollack S
Curr Issues Mol Biol; 2022 Apr; 44(4):1564-1586. PubMed ID: 35723365
[TBL] [Abstract][Full Text] [Related]
12. Oestrogen receptors pathways to oestrogen responsive elements: the transactivation function-1 acts as the keystone of oestrogen receptor (ER)beta-mediated transcriptional repression of ERalpha.
Gougelet A; Mueller SO; Korach KS; Renoir JM
J Steroid Biochem Mol Biol; 2007 May; 104(3-5):110-22. PubMed ID: 17478088
[TBL] [Abstract][Full Text] [Related]
13. Estrogen receptor alpha negative breast cancer patients: estrogen receptor beta as a therapeutic target.
Skliris GP; Leygue E; Watson PH; Murphy LC
J Steroid Biochem Mol Biol; 2008 Mar; 109(1-2):1-10. PubMed ID: 18243688
[TBL] [Abstract][Full Text] [Related]
14. Estrogen receptor alpha/beta isoforms, but not betacx, modulate unique patterns of gene expression and cell proliferation in Hs578T cells.
Secreto FJ; Monroe DG; Dutta S; Ingle JN; Spelsberg TC
J Cell Biochem; 2007 Aug; 101(5):1125-47. PubMed ID: 17520659
[TBL] [Abstract][Full Text] [Related]
15. Preferential estrogen receptor β ligands reduce Bcl-2 expression in hormone-resistant breast cancer cells to increase autophagy.
Ruddy SC; Lau R; Cabrita MA; McGregor C; McKay BC; Murphy LC; Wright JS; Durst T; Pratt MA
Mol Cancer Ther; 2014 Jul; 13(7):1882-93. PubMed ID: 24785256
[TBL] [Abstract][Full Text] [Related]
16. Global analysis of estrogen receptor beta binding to breast cancer cell genome reveals an extensive interplay with estrogen receptor alpha for target gene regulation.
Grober OM; Mutarelli M; Giurato G; Ravo M; Cicatiello L; De Filippo MR; Ferraro L; Nassa G; Papa MF; Paris O; Tarallo R; Luo S; Schroth GP; Benes V; Weisz A
BMC Genomics; 2011 Jan; 12():36. PubMed ID: 21235772
[TBL] [Abstract][Full Text] [Related]
17. The estrogen receptor-interacting protein HPIP increases estrogen-responsive gene expression through activation of MAPK and AKT.
Wang X; Yang Z; Zhang H; Ding L; Li X; Zhu C; Zheng Y; Ye Q
Biochim Biophys Acta; 2008 Jun; 1783(6):1220-8. PubMed ID: 18302941
[TBL] [Abstract][Full Text] [Related]
18. Recruited T cells promote the bladder cancer metastasis via up-regulation of the estrogen receptor β/IL-1/c-MET signals.
Tao L; Qiu J; Slavin S; Ou Z; Liu Z; Ge J; Zuo L; Guancial EA; Messing EM; Chang C; Yeh S
Cancer Lett; 2018 Aug; 430():215-223. PubMed ID: 29684419
[TBL] [Abstract][Full Text] [Related]
19. Estrogen receptor β represses Akt signaling in breast cancer cells via downregulation of HER2/HER3 and upregulation of PTEN: implications for tamoxifen sensitivity.
Lindberg K; Helguero LA; Omoto Y; Gustafsson JÅ; Haldosén LA
Breast Cancer Res; 2011 Apr; 13(2):R43. PubMed ID: 21492444
[TBL] [Abstract][Full Text] [Related]
20. Stimulatory cross-talk between NFAT3 and estrogen receptor in breast cancer cells.
Zhang H; Xie X; Zhu X; Zhu J; Hao C; Lu Q; Ding L; Liu Y; Zhou L; Liu Y; Huang C; Wen C; Ye Q
J Biol Chem; 2005 Dec; 280(52):43188-97. PubMed ID: 16219765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
